Nootropic agent

Details Nootropic agent Nootropic agent

A - Human Necessities

61

K

A61K 31/70 (2006.01) C07H 19/20 (2006.01)

Patent

CA 2049977

ABSTRACT OF THE DISCLOSURE The present invention relates to a nootropic agent which comprises an adenosine-3',5'-cyclic monophosphate derivative represented by the following formula (I): (I) Image wherein R1 represents a hydrogen atom, a lower alkyl group or a lower acyl group; R2 represents a hydrogen atom or an aralkylthio group; and R3 represents a hydrogen atom or a lower acyl group, or a salt thereof as an active ingredient. The nootropic agent of the present invention is effective in the treatment of cerebrovascular dementia, dementia such as Alzheimer's disease, psychopathy such as depression, neuropathy such as Parkinson's disease, degenerative or regressive disease in central nervous system, cerebral disorders caused by cerebral hemorrhage or cerebral ischemia such as cerebral infarct and cerebral disorders caused by trauma such as bruise. - 14 -

Affiliated with

Also associated with

Rating

Nootropic agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nootropic agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nootropic agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1536654